Shared Clavulanate and Tazobactam Antigenic Determinants Activate T-Cells from Hypersensitive Patients. (2022)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.chemrestox.2c00231
PubMed Identifier: 36137197
Publication URI: http://europepmc.org/abstract/MED/36137197
Type: Journal Article/Review
Volume: 35
Parent Publication: Chemical research in toxicology
Issue: 11
ISSN: 0893-228X